Clinical Trial Update: TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY [NA]

View source ↗

Summary

A clinical trial evaluating the combination of TGF-β inhibition and PD-L1 inhibition with chemoradiation for esophageal squamous cell carcinoma, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• PD-L1 inhibitor (Programmed death-ligand 1 inhibitor)
• TGF-β inhibitor (Transforming growth factor beta inhibitor)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Carcinoma, Squamous Cell, Oesophageal Cancer | NA | Status: RECRUITING